HumanOptics AG: Chinese investor new majority shareholder of HumanOptics AG - Closing of the share purchase agreement dated 30 August 2019 between Medipart AG and a Chinese investor regarding the majority stake in HumanOptics AG

HumanOptics AG / Key word(s): Miscellaneous
HumanOptics AG: Chinese investor new majority shareholder of HumanOptics AG - Closing of the share purchase agreement dated 30 August 2019 between Medipart AG and a Chinese investor regarding the majority stake in HumanOptics AG

18-Dec-2019 / 16:00 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Erlangen, 18 December 2019 - The Management Board of HumanOptics AG ("Company"), a leading technology company that manufactures implants for eye surgery, was informed today by the (previously existing) majority shareholder of Medipart AG, Unterägeri/Switzerland ("Medipart") that the share purchase agreement concluded between Medipart and a Chinese investor on 30 August 2019 had been consummated. Accordingly, that Chinese investor, via the intermediary HumanOptics Holding AG as an acquisition vehicle, has acquired a 73.4 % stake in the Company's share capital from Medipart and is thus the Company's new majority shareholder.

Contact:

HumanOptics AG
Investor Relations
Spardorfer Str. 150
91054 Erlangen
Telefon: +49 (0) 9131 50665-0
E-Mail: IR@humanoptics.com

18-Dec-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de